Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The only change noted is a minor acquisition of shares by a connected person.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction executed under the Company's ShareReward Plan.
Important Facts for Investors
- Transaction Date: March 9, 2012.
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Details: Acquisition of 2 Ordinary Shares via personal contribution and 2 Ordinary Shares via the matching element (Company contribution).
- Share Price: 1420 pence per Ordinary Share.
- Regulatory Basis: Notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).